Gene · 406940
Papers4,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development. | Int J Mol Sci | 2023 | 38003512 | PubTator, text mining | PubMed |
| Strain Variation Can Significantly Modulate the miRNA Response to Zika Virus Infection. | Int J Mol Sci | 2023 | 38003407 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential. | Int J Mol Sci | 2023 | 38003403 | PubTator, text mining | PubMed |
| Human Breast Milk miRNAs: Their Diversity and Potential for Preventive Strategies in Nutritional Therapy. | Int J Mol Sci | 2023 | 38003296 | PubTator, text mining | PubMed |
| The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management. | Cancers (Basel) | 2023 | 38001722 | PubTator, text mining | PubMed |
| Identification of 3'-terminal 2'-O-methylated miRNA in plasma as a novel diagnostic biomarker of NSCLC. | Clin Transl Med | 2023 | 37997565 | PubTator, text mining | PubMed |
| Alleviation of DSS-induced colitis via bovine colostrum-derived extracellular vesicles with microRNA let-7a-5p is mediated by regulating Akkermansia and β-hydroxybutyrate in gut environments. | Microbiol Spectr | 2023 | 37966243 | PubTator, text mining | PubMed |
| Atherosclerosis and Its Related Laboratory Biomarkers. | Int J Mol Sci | 2023 | 37958528 | PubTator, text mining | PubMed |
| Unveiling Mesenchymal Stem Cells' Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications. | Cells | 2023 | 37947637 | PubTator, text mining | PubMed |
| Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study. | Sci Rep | 2023 | 37945677 | PubTator, text mining | PubMed |
| Spatial exosome analysis using cellulose nanofiber sheets reveals the location heterogeneity of extracellular vesicles. | Nat Commun | 2023 | 37938557 | PubTator, text mining | PubMed |
| Analysis of liver miRNA in Hu sheep with different residual feed intake. | Front Genet | 2023 | 37928243 | PubTator, text mining | PubMed |
| Bell's palsy or an aggressive infiltrating basaloid carcinoma post-mRNA vaccination for COVID-19? A case report and review of the literature. | EXCLI J | 2023 | 37927346 | PubTator, text mining | PubMed |
| Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus. | Lupus | 2023 | 37906972 | PubTator, text mining | PubMed |
| Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma. | World J Gastroenterol | 2023 | 37900996 | PubTator, text mining | PubMed |
| The role of noncoding RNA and its diagnostic potential in intrahepatic cholestasis of pregnancy: a research update. | Front Genet | 2023 | 37900174 | PubTator, text mining | PubMed |
| Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model. | Sci Rep | 2023 | 37898651 | PubTator, text mining | PubMed |
| Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers. | Int J Mol Sci | 2023 | 37895131 | PubTator, text mining | PubMed |
| MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets. | Cancers (Basel) | 2023 | 37894390 | PubTator, text mining | PubMed |
| MicroRNA Profile, Putative Diagnostic Biomarkers and RNA-Based Therapies in the Inherited Lipid Storage Disease Niemann-Pick Type C. | Biomedicines | 2023 | 37892989 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406940/papers?page=10